125 related articles for article (PubMed ID: 17254776)
1. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.
Byrne B; Welsh J
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):703-7. PubMed ID: 17254776
[TBL] [Abstract][Full Text] [Related]
2. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
3. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.
Kemmis CM; Welsh J
J Cell Biochem; 2008 Nov; 105(4):980-8. PubMed ID: 18767073
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
Perez-Fernandez R; Seoane S; Garcia-Caballero T; Segura C; Macia M
Curr Med Chem; 2007; 14(29):3051-8. PubMed ID: 18220741
[TBL] [Abstract][Full Text] [Related]
6. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
7. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.
Johnson AL; Zinser GM; Waltz SE
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E674-85. PubMed ID: 25139050
[TBL] [Abstract][Full Text] [Related]
8. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
9. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
10. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice.
Zinser GM; Welsh J
Mol Endocrinol; 2004 Sep; 18(9):2208-23. PubMed ID: 15178742
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of mammary carcinogenesis by 1alpha-hydroxyvitamin D5, a synthetic analog of Vitamin D.
Mehta RG; Hussain EA; Mehta RR; Das Gupta TK
Mutat Res; 2003; 523-524():253-64. PubMed ID: 12628523
[TBL] [Abstract][Full Text] [Related]
14. Calcium signaling in cancer and vitamin D.
Sergeev IN
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):145-51. PubMed ID: 16081284
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.
Cui X; Pertile R; Liu P; Eyles DW
Neuroscience; 2015 Sep; 304():90-100. PubMed ID: 26210580
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D-3 receptor as a target for breast cancer prevention.
Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
20. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
